share_log

$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying

$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying

這間醫療保健股票投資400萬美元?看看這3支股票內部人士正在購買
Benzinga ·  06/04 09:11

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

儘管週一美國股市收盤漲跌互現,但仍有一些值得注意的內幕交易。

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

當內部人士購買股票時,這表明他們對公司前景充滿信心,或者他們認爲股票很划算。無論哪種方式,這都預示着做多該股的機會。不應將內幕購買視爲做出投資或交易決策的唯一指標。充其量,它可以爲購買決定提供信心。

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

以下是最近幾次值得注意的內幕收購。欲了解更多信息,請訪問Benzinga的內幕交易平台。

DENTSPLY SIRONA

DENTSPLY SIRONA

  • The Trade: DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T Lucier acquired a total of 3,577 shares at an average price of $27.95. To acquire these shares, it cost around $99,976.
  • What's Happening: On May 2, the company reported adjusted earnings per share of 42 cents, in line with the street view.
  • What DENTSPLY SIRONA Does: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies.
  • 交易:DENTSPLY SIRONA Inc.(納斯達克股票代碼:XRAY)董事格雷戈裏·盧西爾共收購了3577股股票,平均價格爲27.95美元。收購這些股票的成本約爲99,976美元。
  • 發生了什麼:5月2日,該公司公佈的調整後每股收益爲42美分,與街景一致。
  • DENTSPLY SIRONA 做什麼:Dentsply Sirona 是世界上最大的牙科設備和用品製造商之一。

CARGO Therapeutics

CARGO 療法

  • The Trade: CARGO Therapeutics, Inc. (NASDAQ:CRGX) 10% owner Srinivas Akkaraju acquired a total of 294,000 shares at an average price of $17.00. To acquire these shares, it cost around $5 million.
  • What's Happening: On May 28, CARGO Therapeutics announced it entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of approximately $110.0 million.
  • What CARGO Therapeutics Does: Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients.
  • 交易:CARGO Therapeutics, Inc.(納斯達克股票代碼:CRGX)10%的所有者Srinivas Akkaraju共收購了29.4萬股股票,平均價格爲17.00美元。收購這些股票的成本約爲500萬美元。
  • 發生了什麼:5月28日,CARGO Therapeutics宣佈簽訂了一項證券購買協議,對公共股權融資進行私人投資,預計將產生約1.1億美元的總收益。
  • CARGO Therapeutics的所作所爲:Cargo Therapeutics Inc是一家處於臨床階段的生物技術公司,旨在推進針對癌症患者的下一代可能具有治療作用的細胞療法。

Wintrust Financial

盈信金融

  • The Trade: Wintrust Financial Corporation (NASDAQ:WTFC) Director, Founder and Senior Advisor Edward J Wehmer bought a total of 1,197 shares at an average price of $24.64. To acquire these shares, it cost around $29,489.
  • What's Happening: On April 17, Wintrust Finl posted upbeat quarterly earnings.
  • What Wintrust Financial Does: Wintrust Financial Corp is a financial holding company operating in the Chicago metropolitan area and southern Wisconsin through its wholly-owned banking subsidiaries.
  • 交易:Wintrust Financial Corporation(納斯達克股票代碼:WTFC)董事、創始人兼高級顧問愛德華·韋默共購買了1,197股股票,平均價格爲24.64美元。收購這些股票的成本約爲29,489美元。
  • 發生了什麼:4月17日,Wintrust Finl公佈了樂觀的季度收益。
  • Wintrust Financial的所作所爲:Wintrust Financial Corp是一家金融控股公司,通過其全資銀行子公司在芝加哥都會區和威斯康星州南部開展業務。

Read More: Top 3 Utilities Stocks That May Plunge In Q2

閱讀更多:第二季度可能暴跌的三大公用事業股

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論